Figure][1] Katherine W. Ferrara, PhD Dr. Katherine W. Ferrara is a professor of radiology at Stanford University and the ...
PET/CT offers excellent accuracy in the staging of high-risk prostate cancer (PCa), yet outcomes-based evidence of the clinical benefit remains limited. We aimed to determine whether the rates of ...
Journal of Nuclear Medicine April 2026, jnumed.126.272026; DOI: https://doi.org/10.2967/jnumed.126.272026 As radiopharmaceutical therapy (RPT) expands beyond ...
Journal of Nuclear Medicine May 2026, jnumed.125.272001; DOI: https://doi.org/10.2967/jnumed.125.272001 ...
Journal of Nuclear Medicine May 2026, jnumed.125.271348; DOI: https://doi.org/10.2967/jnumed.125.271348 ...
Phase 2 Prospective Trial of Retreatment with [177 Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer—RE-LuPSMA ...
Learning Objectives 1. Understand the additional value of combined Tc99m-HDP SPECT/CT evaluation in benign and malignant conditions. 2. Recognize different imaging patterns of uptake and its ...
Journal of Nuclear Medicine April 2026, jnumed.125.271880; DOI: https://doi.org/10.2967/jnumed.125.271880 ...
Journal of Nuclear Medicine April 2026, jnumed.125.271604; DOI: https://doi.org/10.2967/jnumed.125.271604 ...
Transplantation of stem cells or immune cells has shown promise for the treatment of several diseases. Monitoring magnetically labeled cells with MRI has furthered our understanding of cellular ...